Company news

Galectin Therapeutics Inc. news in 2025

Galectin Therapeutics Inc.'s news releases, calls and decks from 2025, newest first.

View company

Galectin Therapeutics Provides Regulatory Update Following FDA Written Response and Announces an Additional $10 Million Line of Credit from Richard E. Uihlein Sufficient to Cover Expected Expenditures Through March 2027

December 19, 2025

Galectin Therapeutics Reports Financial Results for the quarter ended September 30, 2025, and Provides Business Update

November 14, 2025

Galectin Therapeutics Presented NAVIGATE Trial Results at the American Association for the Study of Liver Diseases (AASLD) 2025 Annual Meeting

November 10, 2025

Galectin Therapeutics to Present at the H.C. Wainwright 9th Annual MASH Investor Conference

October 19, 2025

Galectin Therapeutics to Present at the American Association for the Study of Liver Disease (AASLD) Liver Meeting 2025

October 7, 2025

Galectin Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference

September 2, 2025

Galectin Therapeutics Reports Financial Results for the Quarter Ended June 30, 2025 and Provides Business Update

August 14, 2025

Galectin Therapeutics Announces New $10 Million Credit Line from Richard E. Uihlein, Sufficient to Cover Expected Expenditures Through June 2026

July 9, 2025

Galectin Therapeutics to Host Virtual KOL Event to Discuss Belapectin for Treatment of MASH Cirrhosis and Portal Hypertension

June 10, 2025

Galectin Therapeutics Reports Financial Results for the Quarter Ended March 31, 2025 and Provides Business Update

May 15, 2025

Galectin Therapeutics Presented NAVIGATE Trial Results at the European Association for the Study of the Liver (EASL) 2025 Congress

May 12, 2025

Galectin Therapeutics to Present at the European Association for the Study of the Liver (EASL) 2025 Congress

April 15, 2025

Galectin Therapeutics Reports 2024 Financial Results and Provides Business Update

March 31, 2025

Galectin Therapeutics Reports Significant Reduction in New Varices with Belapectin in U.S. Patient Population from the NAVIGATE Trial

February 18, 2025

Galectin Therapeutics to Present at the 2025 MASH-TAG Conference

January 9, 2025

Decks in 2025